Veterinary Medicines

BIOSUIS LEPTO P

Authorised
  • Porcine parvovirus, Inactivated
  • Leptospira interrogans, Serogroup Pomona, Inactivated
  • Leptospira borgpetersenii, serogroup Sejroe, serovar Hardjo, strain MSLB 1039, Inactivated
  • Leptospira interrogans, serogroup Australis, serovar Bratislava, Inactivated
  • Leptospira interrogans, serogroup Grippotyphosa, serovar Grippotyphosa, Inactivated
  • Leptospira interrogans, serogroup Icterohaemorrhagiae, serovar Icterohaemorrhagiae, strain MSLB 1041, Inactivated
  • Leptospira interrogans, serogroup Canicola, serovar Canicola, strain MSLB 1043, Inactivated
Download as PDF

Product identification

Medicine name:
BIOSUIS LEPTO P
Active substance:
  • Porcine parvovirus, Inactivated
  • Leptospira interrogans, Serogroup Pomona, Inactivated
  • Leptospira borgpetersenii, serogroup Sejroe, serovar Hardjo, strain MSLB 1039, Inactivated
  • Leptospira interrogans, serogroup Australis, serovar Bratislava, Inactivated
  • Leptospira interrogans, serogroup Grippotyphosa, serovar Grippotyphosa, Inactivated
  • Leptospira interrogans, serogroup Icterohaemorrhagiae, serovar Icterohaemorrhagiae, strain MSLB 1041, Inactivated
  • Leptospira interrogans, serogroup Canicola, serovar Canicola, strain MSLB 1043, Inactivated
Target species:
This information is not available for this product.
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Porcine parvovirus, Inactivated
  • Leptospira interrogans, Serogroup Pomona, Inactivated
    32.00
    Antibody microagglutination-lytic reaction
    /
    1.00
    Dose
  • Leptospira borgpetersenii, serogroup Sejroe, serovar Hardjo, strain MSLB 1039, Inactivated
    32.00
    Antibody microagglutination-lytic reaction
    /
    1.00
    Dose
  • Leptospira interrogans, serogroup Australis, serovar Bratislava, Inactivated
    32.00
    Antibody microagglutination-lytic reaction
    /
    1.00
    Dose
  • Leptospira interrogans, serogroup Grippotyphosa, serovar Grippotyphosa, Inactivated
    35.00
    Antibody microagglutination-lytic reaction
    /
    1.00
    Dose
  • Leptospira interrogans, serogroup Icterohaemorrhagiae, serovar Icterohaemorrhagiae, strain MSLB 1041, Inactivated
    32.00
    Antibody microagglutination-lytic reaction
    /
    1.00
    Dose
  • Leptospira interrogans, serogroup Canicola, serovar Canicola, strain MSLB 1043, Inactivated
    32.00
    Antibody microagglutination-lytic reaction
    /
    1.00
    Dose
Pharmaceutical form:
  • Emulsion for injection
Withdrawal period by route of administration:
  • Intramuscular use
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI09AL
Legal status of supply:
This information is not available for this product.
Authorisation status:
  • Valid
Authorised in:
  • Romania
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Complete application (stand-alone) - Directive No 2001/82/EC
Marketing authorisation holder:
  • Bioveta Romania S.R.L.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Bioveta a.s.
Responsible authority:
  • Institute For Control Of Biological Products And Veterinary Medicines
Authorisation number:
  • 190314
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Romanian (PDF)
Published on: 23/05/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."